[1]
|
Naderi, S., Wang, Y., Miller, A.L., Rodriguez, F., Chung, M.K., Radford, M.J. and Foody, J.M. (2014) The Impact of Age on the Epidemiology of Atrial Fibrillation Hospitalizations. American Journal of Medicine, 127, 158.e1-158.e7. http://dx.doi.org/10.1016/j.amjmed.2013.10.005
|
[2]
|
Camm, J. (2005) Atrial Fibrillation—An End to the Epidemic? Circulation, 112, iii.
|
[3]
|
Colilla, S., Crow, A., Petkun, W., Singer, D., Simon, T. and Liu, X.C. (2013) Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population. American Journal of Cardiology, 112, 1142-1147. http://dx.doi.org/10.1016/j.amjcard.2013.05.063
|
[4]
|
Kim, M.H., Johnston, S.S., Chu, B.C., Dalal, M.R. and Schulman, K.L. (2011) Estimation of Total Incremental Health Care Costs in Patients with Atrial Fibrillation in the United States. Circulation: Cardiovascular Quality and Outcomes, 4, 313-320. http://dx.doi.org/10.1161/CIRCOUTCOMES.110.958165
|
[5]
|
Karamichalakis, N., Letsas, K.P., Vlachos, K., Georgopoulos, S., Bakalakos, A., Efremidis, M. and Sideris, A. (2015) Managing Atrial Fibrillation in the Very Elderly Patient: Challenges and Solutions. Vascular Health and Risk Management, 11, 555-562. http://dx.doi.org/10.2147/VHRM.S83664
|
[6]
|
Kyprianou, K., Pericleous, A., Stavrou, A., Dimitrakaki, I.A., Challoumas, D. and Dimitrakakis, G. (2016) Surgical Perspectives in the Management of Atrial Fibrillation. World Journal of Cardiology, 8, 41-56. http://dx.doi.org/10.4330/wjc.v8.i1.41
|
[7]
|
Benjamin, E.J., Wolf, P.A., D’Agostino, R.B., Silbershatz, H., Kannel, W.B. and Levy, D. (1998) Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study. Circulation, 98, 946-952. http://dx.doi.org/10.1161/01.CIR.98.10.946
|
[8]
|
Takigawa, M., Takahashi, A., Kuwahara, T., Okubo, K., Takahashi, Y., Watari, Y., Takagi, K., Fujino, T., Kimura, S., Hikita, H., Tomita, M., Hirao, K. and Isobe, M. (2014) Long-Term Follow-Up after Catheter Ablation of Paroxysmal Atrial Fibrillation: The Incidence of Recurrence and Progression of Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology, 7, 267-273. http://dx.doi.org/10.1161/CIRCEP.113.000471
|
[9]
|
Fosbol, E.L., Holmes, D.N., Piccini, J.P., Thomas, L., Reiffel, J.A., Mills, R.M., Kowey, P., Mahaffey, K., Gersh, B.J., Peterson, E.D., the ORBIT-AF Investigators and Patients (2013) Provider Specialty and Atrial Fibrillation Treatment Strategies in United States Community Practice: Findings from the ORBIT-AF Registry. Journal of the American Heart Association, 2, e000110. http://dx.doi.org/10.1161/JAHA.113.000110
|
[10]
|
Calkins, H., Kuck, K.H., Cappato, R., Brugada, J., Camm, A.J., Chen, S.A., Crijns, H.J., Damiano Jr., R.J., Davies, D.W., DiMarco, J., Edgerton, J., Ellenbogen, K., Ezekowitz, M.D., Haines, D.E., Haissaguerre, M., Hindricks, G., Iesaka, Y., Jackman, W., Jalife, J., Jais, P., Kalman, J., Keane, D., Kim, Y.H., Kirchhof, P., Klein, G., Kottkamp, H., Kumagai, K., Lindsay, B.D., Mansour, M., Marchlinski, F.E., McCarthy, P.M., Mont, J.L., Morady, F., Nademanee, K., Nakagawa, H., Natale, A., Nattel, S., Packer, D.L., Pappone, C., Prystowsky, E., Raviele, A., Reddy, V., Ruskin, J.N., Shemin, R.J., Tsao, H.M. and Wilber, D. (2012) 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-Up, Definitions, Endpoints, and Research Trial Design. Europace, 14, 528-606. http://dx.doi.org/10.1093/europace/eus027
|
[11]
|
Shah, R.U., Freeman, J.V., Shilane, D., Wang, P.J., Go, A.S. and Hlatky, M.A. (2012) Procedural Complications, Rehospitalizations, and Repeat Procedures after Catheter Ablation for Atrial Fibrillation. Journal of the American College of Cardiology, 59, 143-149. http://dx.doi.org/10.1016/j.jacc.2011.08.068
|
[12]
|
Deshmukh, A., Patel, N.J., Pant, S., Shah, N., Chothani, A., Mehta, K., Grover, P., Singh, V., Vallurupalli, S., Savani, G.T., Badheka, A., Tuliani, T., Dabhadkar, K., Dibu, G., Reddy, Y.M., Sewani, A., Kowalski, M., Mitrani, R., Paydak, H. and Viles-Gonzalez, J.F. (2013) In-Hospital Complications Associated with Catheter Ablation of Atrial Fibrillation in the United States between 2000 and 2010: Analysis of 93,801 Procedures. Circulation, 128, 2104-2112. http://dx.doi.org/10.1161/CIRCULATIONAHA.113.003862
|
[13]
|
Cappato, R., Calkins, H., Chen, S.A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.H., Klein, G., Natale, A., Packer, D. and Skanes, A. (2009) Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation. Journal of the American College of Cardiology, 53, 1798-1803. http://dx.doi.org/10.1016/j.jacc.2009.02.022
|
[14]
|
Cappato, R., Calkins, H., Chen, S.A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.H., Klein, G., Natale, A., Packer, D., Skanes, A., Ambrogi, F. and Biganzoli, E. (2010) Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology, 3, 32-38. http://dx.doi.org/10.1161/CIRCEP.109.859116
|
[15]
|
Cappato, R., Calkins, H., Chen, S.A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.H., Klein, G., Packer, D. and Skanes, A. (2005) Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation. Circulation, 111, 1100-1105. http://dx.doi.org/10.1161/01.CIR.0000157153.30978.67
|
[16]
|
Chen, S.-A. and Tai, C.-T. (2005) Catheter Ablation of Atrial Fibrillation Originating from the Non-Pulmonary Vein Foci. Journal of Cardiovascular Electrophysiology, 16, 229-232. http://dx.doi.org/10.1046/j.1540-8167.2005.40665.x
|
[17]
|
Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., Gulletta, S., Gugliotta, F., Pappone, A., Santinelli, V., Tortoriello, V., Sala, S., Zangrillo, A., Crescenzi, G., Benussi, S. and Alfieri, O. (2003) Mortality, Morbidity, and Quality of Life after Circumferential Pulmonary Vein Ablation for Atrial Fibrillation: Outcomes from a Controlled Nonrandomized Long-Term Study. Journal of the American College of Cardiology, 42, 185-197. http://dx.doi.org/10.1016/S0735-1097(03)00577-1
|
[18]
|
Kobza, R., Hindricks, G., Tanner, H., Schirdewahn, P., Dorszewski, A., Piorkowski, C., Gerds-Li, J.H. and Kottkamp, H. (2004) Late Recurrent Arrhythmias after Ablation of Atrial Fibrillation: Incidence, Mechanisms, and Treatment. Heart Rhythm, 1, 676-683. http://dx.doi.org/10.1016/j.hrthm.2004.08.009
|
[19]
|
Winkle, R.A., Mead, R.H., Engel, G. and Patrawala, R.A. (2011) Long-Term Results of Atrial Fibrillation Ablation: The Importance of All Initial Ablation Failures Undergoing a Repeat Ablation. American Heart Journal, 162, 193-200. http://dx.doi.org/10.1016/j.ahj.2011.04.013
|
[20]
|
Wazni, O.M., Marrouche, N.F., Martin, D.O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., Gutleben, K., Pisano, E., Potenza, D., Fanelli, R., Raviele, A., Themistoclakis, S., Rossillo, A., Bonso, A. and Natale, A. (2005) Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial. JAMA, 293, 2634-2640. http://dx.doi.org/10.1001/jama.293.21.2634
|
[21]
|
Stabile, G., Bertaglia, E., Senatore, G., De Simone, A., Zoppo, F., Donnici, G., Turco, P., Pascotto, P., Fazzari, M. and Vitale, D.F. (2006) Catheter Ablation Treatment in Patients with Drug-Refractory Atrial Fibrillation: A Prospective, Multi-Centre, Randomized, Controlled Study (Catheter Ablation for the Cure of Atrial Fibrillation Study). European Heart Journal, 27, 216-221. http://dx.doi.org/10.1093/eurheartj/ehi583
|
[22]
|
Weerasooriya, R., Khairy, P., Litalien, J., Macle, L., Hocini, M., Sacher, F., Lellouche, N., Knecht, S., Wright, M., Nault, I., Miyazaki, S., Scavee, C., Clementy, J., Haissaguerre, M. and Jais, P. (2011) Catheter Ablation for Atrial Fibrillation: Are Results Maintained at 5 Years of Follow-Up? Journal of the American College of Cardiology, 57, 160-166. http://dx.doi.org/10.1016/j.jacc.2010.05.061
|
[23]
|
Shah, A.N., Mittal, S., Sichrovsky, T.C., Cotiga, D., Arshad, A., Maleki, K., Pierce, W.J. and Steinberg, J.S. (2008) Long-Term Outcome Following Successful Pulmonary Vein Isolation: Pattern and Prediction of Very Late Recurrence. Journal of Cardiovascular Electrophysiology, 19, 661-667. http://dx.doi.org/10.1111/j.1540-8167.2008.01101.x
|
[24]
|
Ouyang, F., Tilz, R., Chun, J., Schmidt, B., Wissner, E., Zerm, T., Neven, K., Kokturk, B., Konstantinidou, M., Metzner, A., Fuernkranz, A. and Kuck, K.H. (2010) Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation: Lessons from a 5-Year Follow-Up. Circulation, 122, 2368-2377. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.946806
|
[25]
|
Sawhney, N., Anousheh, R., Chen, W.C., Narayan, S. and Feld, G.K. (2009) Five-Year Outcomes after Segmental Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation. The American Journal of Cardiology, 104, 366-372. http://dx.doi.org/10.1016/j.amjcard.2009.03.044
|
[26]
|
Wokhlu, A., Hodge, D.O., Monahan, K.H., Asirvatham, S.J., Friedman, P.A., Munger, T.M., Cha, Y.M., Shen, W.K., Brady, P.A., Bluhm, C.M., Haroldson, J.M., Hammill, S.C. and Packer, D.L. (2010) Long-Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence. Journal of Cardiovascular Electrophysiology, 21, 1071-1078. http://dx.doi.org/10.1111/j.1540-8167.2010.01786.x
|
[27]
|
Medi, C., Sparks, P.B., Morton, J.B., Kistler, P.M., Halloran, K., Rosso, R., Vohra, J.K., Kumar, S. and Kalman, J.M. (2011) Pulmonary Vein Antral Isolation for Paroxysmal Atrial Fibrillation: Results from Long-Term Follow-Up. Journal of Cardiovascular Electrophysiology, 22, 137-141.
|
[28]
|
Bertaglia, E., Tondo, C., De Simone, A., Zoppo, F., Mantica, M., Turco, P., Iuliano, A., Forleo, G., La Rocca, V. and Stabile, G. (2012) Does Catheter Ablation Cure Atrial Fibrillation? Single-Procedure Outcome of Drug-Refractory Atrial Fibrillation Ablation: A 6-Year Multicentre Experience. Europace, 12, 181-187.
|
[29]
|
Ellis, E.R., Culler, S.D., Simon, A.W. and Reynolds, M.R. (2009) Trends in Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Medicare Beneficiaries. Heart Rhythm, 6, 1267-1273. http://dx.doi.org/10.1016/j.hrthm.2009.06.009
|
[30]
|
Kunimoto, S.Y.K., Yamamoto, K., et al. (2013) Potency of Integrating Three-Dimensional Cardiac Magnetic Resonance Imaging into Electroanatomic Mapping to Perform Catheter Ablation in Pediatrics. Journal of Cardiovascular Magnetic Resonance, 15, M9. http://dx.doi.org/10.1186/1532-429X-15-S1-M9
|
[31]
|
Mills, L.C., Gow, R.M., Myers, K., Kantoch, M.J., Gross, G.J., Fournier, A. and Sanatani, S. (2013) Lone Atrial Fibrillation in the Pediatric Population. Canadian Journal of Cardiology, 29, 1227-1233. http://dx.doi.org/10.1016/j.cjca.2013.06.014
|
[32]
|
Zimetbaum, P. (2012) Anti-arrhythmic Drug Therapy for Atrial Fibrillation. Circulation, 125, 381-389. http://dx.doi.org/10.1161/CIRCULATIONAHA.111.019927
|
[33]
|
Huang, D.T., Monahan, K.M., Zimetbaum, P., Papageorgiou, P., Epstein, L.M. and Josephson, M.E. (1998) Hybrid Pharmacologic and Ablative Therapy: A Novel and Effective Approach for the Management of Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 9, 462-469. http://dx.doi.org/10.1111/j.1540-8167.1998.tb01837.x
|
[34]
|
Nabar, A., Rodriguez, L.M., Timmermans, C., van Mechelen, R. and Wellens, H.J. (2001) Class IC Antiarrhythmic Drug Induced Atrial Flutter: Electrocardiographic and Electrophysiological Findings and Their Importance for Long Term Outcome after Right Atrial Isthmus Ablation. Heart, 85, 424-429. http://dx.doi.org/10.1136/heart.85.4.424
|
[35]
|
Gentzkow, G.D. and Sullivan, J.Y. (1984) Extracardiac Adverse Effects of Flecainide. The American Journal of Cardiology, 53, B101-B105. http://dx.doi.org/10.1016/0002-9149(84)90511-3
|
[36]
|
Echt, D.S., Liebson, P.R., Mitchell, L.B., Peters, R.W., Obias-Manno, D., Barker, A.H., Arensberg, D., Baker, A., Friedman, L., Greene, H.L., et al. (1991) Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo—The Cardiac Arrhythmia Suppression Trial. The New England Journal of Medicine, 324, 781-788. http://dx.doi.org/10.1056/NEJM199103213241201
|
[37]
|
Olesen, J.B., Lip, G.Y., Kamper, A.L., Hommel, K., Kober, L., Lane, D.A., Lindhardsen, J., Gislason, G.H. and Torp-Pedersen, C. (2012) Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease. The New England Journal of Medicine, 367, 625-635. http://dx.doi.org/10.1056/NEJMoa1105594
|
[38]
|
(1994) Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation: Analysis of Pooled Data from Five Randomized Controlled Trials. Archives of Internal Medicine, 154, 1449-1457.
|
[39]
|
Dzeshka, M.S. and Lip, G.Y.H. (2014) Stroke and Bleeding Risk Assessment: Where Are We Now? Journal of Atrial Fibrilation, 6, 49-57.
|
[40]
|
Camm, A.J., Lip, G.Y., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S.H., Hindricks, G., Kirchhof, P., et al. (2012) 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation: An Update of the 2010 ESC Guidelines for the Management of Atrial Fibrillation Developed with the Special Contribution of the European Heart Rhythm Association. Europace, 14, 1385-1413. http://dx.doi.org/10.1093/europace/eus305
|
[41]
|
Schulman, S., Kearon, C. and The Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of Major Bleeding in Clinical Investigations of Antihemostatic Medicinal Products in Non-Surgical Patients. Journal of Thrombosis and Haemostasis, 3, 692-694. http://dx.doi.org/10.1111/j.1538-7836.2005.01204.x
|
[42]
|
Wizemann, V., Tong, L., Satayathum, S., Disney, A., Akiba, T., Fissell, R.B., Kerr, P.G., Young, E.W. and Robinson, B.M. (2010) Atrial Fibrillation in Hemodialysis Patients: Clinical Features and Associations with Anticoagulant Therapy. Kidney International, 77, 1098-1106. http://dx.doi.org/10.1038/ki.2009.477
|
[43]
|
Chan, K.E., Lazarus, J.M., Thadhani, R. and Hakim, R.M. (2009) Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation. Journal of the American Society of Nephrology, 20, 2223-2233.
|
[44]
|
Yang, F., Chou, D., Schweitzer, P. and Hanon, S. (2010) Warfarin in Haemodialysis Patients with Atrial Fibrillation: What Benefit? Europace, 12, 1666-1672. http://dx.doi.org/10.1093/europace/euq387
|
[45]
|
Lip, G.Y., Frison, L., Halperin, J.L. and Lane, D.A. (2011) Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) Score. Journal of the American College of Cardiology, 57, 173-180. http://dx.doi.org/10.1016/j.jacc.2010.09.024
|
[46]
|
Marinigh, R., Lane, D.A. and Lip, G.Y. (2011) Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation: Implications for Thromboprophylaxis and Bleeding Risk. Journal of the American College of Cardiology, 57, 1339-1348. http://dx.doi.org/10.1016/j.jacc.2010.12.013
|
[47]
|
Abbott, K.C., Trespalacios, F.C., Taylor, A.J. and Agodoa, L.Y. (2003) Atrial Fibrillation in Chronic Dialysis Patients in the United States: Risk Factors for Hospitalization and Mortality. BMC Nephrology, 4, 1. http://dx.doi.org/10.1186/1471-2369-4-1
|
[48]
|
Vazquez, E., Sanchez-Perales, C., Garcia-Garcia, F., Castellano, P., Garcia-Cortes, M.J., Liebana, A. and Lozano, C. (2009) Atrial Fibrillation in Incident Dialysis Patients. Kidney International, 76, 324-330. http://dx.doi.org/10.1038/ki.2009.185
|
[49]
|
Solberg, T.D. and Medin, P.M. (2010) Quality and Safety in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: Can More Be Done? Journal of Radiosurgery and SBRT, 1, 13-19.
|
[50]
|
Betti, O.O. and Derechinsky, Y. (1984) Hyperselective Encephalic Irradiation with Linear Accelerator. In: Gybels, J., Hitchcock, E.R., Ostertag, C., Rossi, G.F., Siegfried, J. and Szikla, G., Eds., Advances in Stereotactic and Functional Neurosurgery 6, Springer, Vienna, 385-390.
|
[51]
|
Colombo, F., Benedetti, A., Pozza, F., Avanzo, R.C., Marchetti, C., Chierego, G. and Zanardo, A. (1985) External Stereotactic Irradiation by Linear Accelerator. Neurosurgery, 16, 154-160. http://dx.doi.org/10.1227/00006123-198502000-00005
|
[52]
|
Kondziolka, D., Patel, A., Lunsford, L.D., Kassam, A. and Flickinger, J.C. (1999) Stereotactic Radiosurgery plus Whole Brain Radiotherapy versus Radiotherapy Alone for Patients with Multiple Brain Metastases. International Journal of Radiation Oncology*Biology*Physics, 45, 427-434. http://dx.doi.org/10.1016/S0360-3016(99)00198-4
|
[53]
|
Linskey, M.E., Andrews, D.W., Asher, A.L., Burri, S.H., Kondziolka, D., Robinson, P.D., Ammirati, M., Cobbs, C.S., Gaspar, L.E., Loeffler, J.S., McDermott, M., Mehta, M.P., Mikkelsen, T., Olson, J.J., Paleologos, N.A., Patchell, R.A., Ryken, T.C. and Kalkanis, S.N. (2010) The Role of Stereotactic Radiosurgery in the Management of Patients with Newly Diagnosed Brain Metastases: A Systematic Review and Evidence-Based Clinical Practice Guideline. Journal of Neuro-Oncology, 96, 45-68. http://dx.doi.org/10.1007/s11060-009-0073-4
|
[54]
|
Suh, J. (2010) Stereotactic Radiosurgery for the Management of Brain Metastases. The New England Journal of Medicine, 362, 1119-1127. http://dx.doi.org/10.1056/NEJMct0806951
|
[55]
|
Chang, S.D., Main, W., Martin, D.P., Gibbs, I.C. and Heilbrun, M.P. (2003) An Analysis of the Accuracy of the CyberKnife: A Robotic Frameless Stereotactic Radiosurgical System. Neurosurgery, 52, 140-146; Discussion 146-147.
|
[56]
|
Solberg, T.D., Medin, P.M., Mullins, J. and Li, S. (2008) Quality Assurance of Immobilization and Target Localization Systems for Frameless Stereotactic Cranial and Extracranial Hypofractionated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 71, S131-S135. http://dx.doi.org/10.1016/j.ijrobp.2007.05.097
|
[57]
|
Jin, J.Y., Yin, F.F., Tenn, S.E., Medin, P.M. and Solberg, T.D. (2008) Use of the BrainLAB ExacTrac X-Ray 6D System in Image-Guided Radiotherapy. Medical Dosimetry, 33, 124-134. http://dx.doi.org/10.1016/j.meddos.2008.02.005
|
[58]
|
Furweger, C., Drexler, C., Kufeld, M., Muacevic, A., Wowra, B. and Schlaefer, A. (2010) Patient Motion and Targeting Accuracy in Robotic Spinal Radiosurgery: 260 Single-Fraction Fiducial-Free Cases. International Journal of Radiation Oncology*Biology*Physics, 78, 937-945. http://dx.doi.org/10.1016/j.ijrobp.2009.11.030
|
[59]
|
Gardner, E.A., Sumanaweera, T.S., Blanck, O., Iwamura, A.K., Steel, J.P., Dieterich, S. and Maguire, P. (2012) In Vivo Dose Measurement Using TLDs and MOSFET Dosimeters for Cardiac Radiosurgery. Journal of Applied Clinical Medical Physics, 13, 3745.
|
[60]
|
Sharma, A., Wong, D., Weidlich, G., Fogarty, T., Jack, A., Sumanaweera, T. and Maguire, P. (2010) Noninvasive Stereotactic Radiosurgery (CyberHeart) for Creation of Ablation Lesions in the Atrium. Heart Rhythm, 7, 802-810. http://dx.doi.org/10.1016/j.hrthm.2010.02.010
|
[61]
|
Klemm, H.U., Franzen, O., Ventura, R. and Willems, S. (2007) Catheter Based Simultaneous Mapping of Cardiac Activation and Motion: A Review. Indian Pacing and Electrophysiology Journal, 7, 148-159.
|